All the Active Ingredient Drugs
TEVIMBRA
BeiGene Pharmaceuticals Israel Ltd.
TEVIMBRA
Anti PD-1 Monoclonal Antibody. tislelizumab 100 mg. Vial. Conc. for sol. for infus. 100 mg/10 ml (1 or 2 Vials)
Dose: 200 mg IV once /3 weeks.
Treat until dis. progress. or unacceptable tox.
Oesophageal sq. cell carcinoma (OSCC)
As monother. for adlts. with unresectable, locally adv. or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemother.
C/I: Hypersens